SCHEMBL23367202

SCHEMBL23367202

O=C(OCc1ccccc1)c1noc(C(=O)O)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
TDP1 Q9NUW8 4/20 0.50
KMT2A Q03164 2/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A3 Q01959 1/20 0.50
LMNA P02545 2/20 0.46
CES1 P23141 1/20 0.46
TSHR P16473 3/20 0.46
MMP2 P08253 2/20 0.44
MMP9 P14780 2/20 0.44
MMP12 P39900 2/20 0.44
MMP1 P03956 1/20 0.44
POLB P06746 2/20 0.43
MAPK1 P28482 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ADORA3 P0DMS8 1/20 0.42
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23367206 0.86 MMP2 (0.49) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL18927560 0.82 POLB (0.54) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL22001034 0.79 HDAC4 (0.46) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL19465373 0.79 MMP2 (0.50) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL14768871 0.79 TDP1 (0.66) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL19975800 0.77 TDP1 (0.54) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL21538018 0.76 TDP1 (0.66) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL27252996 0.74 TDP1 (0.54) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL22624524 0.73 TDP1 (0.46) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL20278543 0.73 TDP1 (0.53) ALDH1A1TDP1KMT2ASLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024115512-A1 MICROBIOCIDAL TETRAHYDROISOQUINOLINE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2024-06-06 WO disclosed
WO-2024115546-A1 FUNGICIDAL COMPOSITIONS SYNGENTA CROP PROTECTION AG (CH) 2024-06-06 WO disclosed
WO-2024105104-A1 MICROBIOCIDAL TETRAHYDROISOQUINOLINE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2024-05-23 WO disclosed
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
WO-2021094434-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2021-05-20 WO disclosed
EP-3822265-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer AG (DE) 2021-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAMTS1 ALDH1A1 2009/4885TDP1 554/4885KMT2A 3100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.